Gene: FCHSD2
Official Full Name: FCH and double SH3 domains 2provided by HGNC
Gene Summary: Enables phosphatidylinositol-3,4,5-trisphosphate binding activity and phosphatidylinositol-3,4-bisphosphate binding activity. Involved in clathrin-dependent endocytosis and positive regulation of Arp2/3 complex-mediated actin nucleation. Located in clathrin-coated pit and plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO32599 | FCHSD2 Knockout cell line (HeLa) | Human | FCHSD2 | 1:3~1:6 | Negative | Online Inquiry |
KO32600 | FCHSD2 Knockout cell line (HCT 116) | Human | FCHSD2 | 1:2~1:4 | Negative | Online Inquiry |
KO32601 | FCHSD2 Knockout cell line (HEK293) | Human | FCHSD2 | 1:3~1:6 | Negative | Online Inquiry |
KO32602 | FCHSD2 Knockout cell line (A549) | Human | FCHSD2 | 1:3~1:4 | Negative | Online Inquiry |
FCHSD2 Gene Knockout Cell Lines are a line of genetically modified cells designed for the specific purpose of investigating the function of the FCHSD2 gene, which is implicated in various cellular processes including endocytosis and signal transduction. These knockout cell lines are created using advanced CRISPR-Cas9 technology, enabling precise and efficient deletion of the FCHSD2 gene, thereby facilitating studies on the gene's role in cellular mechanisms and disease pathology.
The key mechanism by which FCHSD2 Gene Knockout Cell Lines function is through the complete ablation of FCHSD2 expression, allowing researchers to observe the phenotypic changes and functional consequences arising from the absence of this specific gene. This creates an invaluable model for understanding the cellular pathways that are influenced by FCHSD2, providing insights into oncogenesis, immune responses, and neurodegenerative diseases, among others.
The scientific importance of these cell lines cannot be overstated, as they serve as critical tools in ongoing biomedical research and therapeutic development. In clinical settings, understanding the role of FCHSD2 has the potential to uncover novel targets for drug development and to tailor treatments that improve patient outcomes in diseases where this gene plays a role.
Compared to alternative products, the FCHSD2 Gene Knockout Cell Lines stand out due to their robust validation and reliability. Unlike transient knockdown methods, which can yield inconsistent results, our established knockout cell lines offer stable and reproducible gene deletion. Additionally, the use of CRISPR technology ensures that off-target effects are minimized, allowing for more precise studies.
For researchers and clinicians, these cell lines represent a pivotal resource in the quest for a deeper understanding of complex biological processes and the mechanisms underlying various diseases. By leveraging the unique advantages of our FCHSD2 Gene Knockout Cell Lines, users will be better equipped to drive their research forward with confidence.
With years of experience in genetic modification and cellular biology, our company is dedicated to providing high-quality biological products that empower scientific discovery. We are committed to supporting the research community with innovative solutions that meet and exceed industry standards.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.